Traffic Lights - Latest Updates

Last updated: 05/09/2022

Other updates on this site
Drug Name Classification Clinical Indication Comments
ATOGEPANT (Aquipta®) (NEW) Green For treating acute migraine

In line with NICE TA1172

Funding from 30th July 2026

BECLOMETASONE Inhaler - CFC free (UPDATED) Green Asthma

QVAR® brand recommended for adults. Soprobec® brand recommended only for children.

Clenil Modulite® inhalers are being discontinued. Patients prescribed Clenil Modulite® 50 microgram or 100 microgram inhalers should be switched to the equivalent strength of Soprobec®, in line with the local SBAR and Medicines Supply Notification (MSN)
Soprobec® provides a like-for-like dose of beclometasone dipropionate; however, it does not include a dose counter.
LIRAGLUTIDE (Diavic®) (UPDATED) Green Type 2 diabetes

Diavic® is the preferred liraglutide formulation across LLR.

Available only in line with NICE NG28

Other Updates on this Website

Recent documents from LLR APC and TAS


About the Leicester, Leicestershire and Rutland Area Prescribing Committee

In common with other local health communities, the Leicester, Leicestershire and Rutland Area Prescribing Committee (LLR APC) acknowledges the benefits of having a Leicestershire Health Community-wide strategy for the prescribing of specialist medicines and the managed entry of new drugs and related technologies.

Leicestershire Health Community comprises the Leicester, Leicestershire and Rutland Integrated Care Board, University Hospitals of Leicester (UHL) NHS Trust and Leicestershire Partnership NHS Trust (LPT), amongst which there is a total consensus on the need for this strategy, and the LLR APC has been in place since 2005. Learn more